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DNA methylation is the most studied epigenetic modiﬁcation, capable of controlling
gene expression in the contexts of normal traits or diseases. It is highly dynamic during
early embryogenesis and remains relatively stable throughout life, and such patterns
are intricately related to human development. DNA methylation is a quantitative trait
determined by a complex interplay of genetic and environmental factors. Genetic variants at
a speciﬁc locus can inﬂuence both regional and distant DNA methylation.The environment
can have varying effects on DNA methylation depending on when the exposure occurs,
such as during prenatal life or during adulthood. In particular, cigarette smoking in
the context of both current smoking and prenatal exposure is a strong modiﬁer of
DNA methylation. Epigenome-wide association studies have uncovered candidate genes
associated with cigarette smoking that have biologically relevant functions in the etiology
of smoking-related diseases. As such, DNA methylation is a potential mechanistic link
between current smoking and cancer, as well as prenatal cigarette-smoke exposure and
the development of adult chronic diseases.
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INTRODUCTION
Methylation is a chemical modiﬁcation of DNA that modulates
transcription of genetic information from DNA to RNA and, in
this manner, can inﬂuence the expression of a given phenotype
(normal traits or diseases). The rate of methylation at a given
DNA site is a quantitative trait regulated by a complex interplay
of genetic and environmental factors. Here, we review the current
understanding of this interplay, with a special focus on exposure
to cigarette smoking – a common environmental factor acting
throughout the human lifespan.
DNA METHYLATION
DEFINITION OF DNA METHYLATION
Methylation of DNA is the addition of a methyl group at the
5′ position of cytosines in CpG dinucleotides (CpGs; Rakyan
et al., 2011). Cytosines in CpA, CpC, and CpT dinucleotides
can also be methylated, but less frequently (Rakyan et al., 2011).
In addition, methylated cytosines can oxidize and form 5-
hydroxymethylcytosines (Ficz et al., 2011); this event is even less
common (Dahl et al., 2011).
DNA methylation at a single CpG site within a single DNA
strand is a binary trait – the site is either methylated or not. But
experimental samples, such as DNA extracted from lymphocytes,
contain a large number of DNA strands. Some of these strands are
methylated and others not; therefore, DNA methylation at a single
CpG site in an experimental sample is a quantitative trait, being
a proportion of DNA strands that is methylated (Bibikova et al.,
2011).
GENOME DISTRIBUTION OF DNA METHYLATION
The CpG dinucleotides make up only about 1% of the human
genome, which is less than one-fourth of the expected pro-
portion if they were to be randomly distributed; the lower
occurrence of CpGs is thought to be due to a high rate of
spontaneous mutations of methylated CpGs to TpGs (Han et al.,
2008). TheCpGdinucleotides cluster within so-calledCpG islands
(CGIs), which are usually deﬁned as 500-bp to 2-kb segments
of DNA that exhibit at least 50% CG content and a ratio of
observed CpGs to expected CpGs greater than 0.6 (Han et al.,
2008; Rakyan et al., 2011). There are approximately 50,200 CGIs
in the human genome; they are found most abundantly in gene
promoters and repetitive DNA elements. The repetitive DNA ele-
ments are short and long interspersed repeats, or tandem repeats,
such as mini- and microsatellites, that make up >50% of the
genome (Lander et al., 2001). CGIs also exist in gene bodies
(especially in exons) but these are less common (Medvedeva et al.,
2010).
Not all CpGs are methylated. Bisulﬁte-DNA sequencing of
human chromosomes indicates that up to 30% of CpGs are
unmethylated (i.e.,<20%of DNAmoleculesmethylated) and over
40% of CpGs are hypermethylated (i.e.,>80% of DNA molecules
methylated); the remaining 30% of CpGs are methylated at an
intermediary level (i.e., 20–80% DNA molecules methylated; Eck-
hardt et al., 2006). Gene-promoterCpGs aremainly unmethylated,
while CpGs in gene bodies and repetitiveDNA elements aremostly
methylated (Suzuki andBird, 2008; Maunakea et al., 2010). Finally,
methylation levels are often correlated across multiple neighbor-
ing CpGs and this co-methylation is stronger for CpGs inside CGIs
than outside CGIs (Eckhardt et al., 2006; Bell et al., 2011).
ENZYMES OF DNA METHYLATION
Methylation of DNA is catalyzed by three families of DNA
methyltransferases: DNMT1, DNMT2, and DNMT3 (Jeltsch,
2006a).
DNMT1 is responsible for life-long maintenance of DNA
methylation during cell division – it copies DNA methylation
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marks from the original to the nascent strand during DNA repli-
cation (Tang et al., 2009). Consistent with this role, DNMT1
is expressed ubiquitously in proliferative cells (Jurkowska et al.,
2011); it has a 30- to 40-fold binding preference for hemi-
methylated than unmethylated CpGs (Jeltsch, 2006b). DNMT1
does not appear to have a speciﬁc target DNA sequence (Jeltsch,
2006a). Instead, through its interaction with the DNA replication
machinery, DNMT1 is tethered to the replication fork where it
methylates DNA using a hemi-methylated template (Jurkowska
et al., 2011).
DNMT2 catalyzesmethylation of small RNAmolecules, instead
of DNA, but it has some residual de novo DNA methyltransferase
activity (Hermann et al., 2003; Jurkowski et al., 2008).
The DNMT3 family of DNA methyltransferases has three
members: DNMT3A, DNMT3B, and DNMT3L. DNMT3A and
DNMT3B are bona ﬁde de novo methyltransferases that methylate
DNA without a template (Tang et al., 2009). DNMT3L lacks DNA
methyltransferase activity but it co-localizes with DNMT3A and
DNMT3B and enhances their activity (Hata et al., 2002; Jurkowska
et al., 2011). In contrast to DNMT1, which maintains life-long
expression in proliferative cells, DNMT3A and DNMT3B are
expressed mainly during early embryogenesis (though they have
some specialized functions in adulthood, such as maintaining
self-renewal of hematopoietic stem cells (Tadokoro et al., 2007),
cooperating with DNMT1 in silencing tumor suppressor genes in
colorectal cancer cells (Rhee et al., 2002), or regulating synaptic
plasticity in the brain (Feng et al., 2010a; LaPlant et al., 2010).
Also in contrast to DNMT1, DNMT3A and DNMT3B appear
to have preferences for certain DNA sequences. For example,
they prefer CpGs ﬂanked by upstream purine bases and down-
stream pyrimidine bases (Handa and Jeltsch, 2005). In addition,
they form tetrameric complexes with DNMT3L (Jia et al., 2007)
and the structural orientation of active sites and ﬁxed spacing
between adjacent complexes allow simultaneous methylation of
CpGs separated by 8–10 bp (Jurkowska et al., 2008, 2011). These
intrinsic properties of de novo DNMTs may inﬂuence how DNA
methylation patterns are established during early embryogenesis.
FUNCTION OF DNA METHYLATION
Themain functions of DNAmethylation are the regulation of gene
expression and protection of genome integrity.
Regulation of gene expression
Methylation of DNA can modulate transcription of DNA to RNA
by inﬂuencing DNA binding of proteins that initiate and per-
form DNA transcription (Portela and Esteller, 2010; Shukla et al.,
2011). Methylation of DNA may do so either directly, through
physical impediment of protein binding, or indirectly, through
chromatin remodeling and its effect on DNA accessibility for pro-
teins that regulate DNA transcription (Portela and Esteller, 2010).
DNA methylation impacts not only the quantity but also the form
of produced RNA; the latter effect is mediated by DNA methyla-
tion modulating the use of alternative promoters (Maunakea et al.,
2010) and splice sites (Shukla et al., 2011).
Methylation of DNA has traditionally been considered an
inhibitor of DNA transcription. This effect is best understood
in the context of gene promoters where DNA methylation can
impair physical binding of transcription enhancers and pro-
mote the recruitment of methyl-CpG-binding domain proteins
that increase chromatin condensation and thus decrease the
DNA accessibility for the transcriptional machinery (Portela and
Esteller, 2010). Consistent with this inhibitory effect of DNA
methylation on DNA transcription, CpGs within 1 kb of tran-
scription start sites are generally hypomethylated (Bell et al., 2011;
Jjingo et al., 2012). The inverse correlation of DNA methyla-
tion and gene expression may also depend on CGI context;
CpG sites outside of CGIs are two times more likely to be
correlated with gene expression than CpG sites within CGIs
(Numata et al., 2012).
In contrast toDNAmethylation in gene promoters, DNAmethy-
lation in gene bodies has been associated with enhanced DNA
transcription (Aran et al., 2011; McGowan et al., 2011). Gene-
body DNA methylation is common in ubiquitously expressed
genes and correlates positively with gene expression at a genome-
wide level (Hellman and Chess, 2007; Suzuki and Bird, 2008;
Ball et al., 2009). It has been proposed that, rather than a cause
of enhanced gene expression, gene-body DNA methylation may
be its consequence (Zilberman et al., 2007; Jjingo et al., 2012).
During early embryogenesis – when DNA methylation patterns
are being established – an open chromatin structure of chro-
mosomal regions containing actively transcribed genes allows
DNMTs to access and methylate DNA. Within these regions,
CpGs in promoters of actively transcribed genes are occupied
by DNA-binding transcription factors and cannot be methy-
lated, but CpGs in gene bodies that are not occupied by these
factors can and are methylated (Jjingo et al., 2012). This pat-
tern of DNA methylation (low in promoters and high in gene
bodies) established during early embryogenesis is then copied
throughout life and, through low promoter methylation, may
contribute to higher expression of these genes (Jeltsch, 2006a;
Ball et al., 2009). Assuming this happens for a large number
of genes, gene-body methylation then correlates positively with
DNA transcription at a genome-wide level (Jjingo et al., 2012).
In addition to this indirect positive relationship between gene-
body methylation and genome-wide gene expression, gene-body
methylation may be involved in suppression of DNA transcrip-
tion directly by, for example, inhibiting alternative promoters
embedded in gene bodies (Maunakea et al., 2010), or by impeding
RNA-polymerase transit and transcription elongation (Zilberman
et al., 2007; Deaton et al., 2011).
Protection of genome integrity
Methylation of DNA protects the genome’s integrity by suppress-
ing mobility of transposable elements (TEs). TEs are repetitive
DNA sequences that have the ability to integrate into new
chromosome locations, through either “cut-and-paste” or “copy-
and-paste” mechanisms (Levin and Moran, 2011). TEs, like
non-transposable repetitive elements, are hypermethylated, result-
ing in their transcriptional silencing (Law and Jacobsen, 2010).
Since the transposition machinery requires TE-encoded enzymes,
suppression of TE transcription by DNA methylation effectively
prevents translocations and gene disruptions (Levin and Moran,
2011). Loss of DNA methylation allows for TE reactivation and
transposition (Tsukahara et al., 2009).
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DNA METHYLATION CHANGES DURING DEVELOPMENT AND AGING
During embryogenesis, DNAmethylation is a highly dynamic trait
(Eckhardt et al., 2006; Talens et al., 2010; Figure 1). Immediately
after fertilization, the zygote genome undergoes global deple-
tion of DNA methylation, reaching its lowest levels at the
pre-implantation-blastocyst stage – the stage when pluripotent
embryonic stem cells form most of the inner cell mass of the
embryo (Feng et al., 2010b). Post-implantation, DNA methyla-
tion patterns are re-established and become relatively stable and
similar to those found in adult somatic cells (Smith et al., 2012).
Mono-allelic DNA methylation within imprinted genes escapes
the global erasure/re-establishment to preserve parent-of-origin
expression (Bartolomei, 2009). Furthermore, the cells that differ-
entiate into primordial germ cells undergo an additional round
of global erasure/re-establishment to reﬂect the sex of the embryo
(Feng et al., 2010b). In both somatic and primordial germ cells,
the global erasure of DNA methylation is mediated by cytosine
deaminases (Bhutani et al., 2010; Popp et al., 2010) and the re-
establishment of DNA methylation patterns is catalyzed mainly
by de novo DNA methyltransferases, DNMT3A and DNMT3B
(Okano et al., 1999; Kato et al., 2007).
The erasure/re-establishment of DNA methylation during
early embryogenesis aids in the process of cell differentiation
(Epsztejn-Litman et al., 2008). Global erasure of DNAmethylation
activates the expression of pluripotency genes, which promote the
development of embryonic stem cells, which are cells capable of
generating any tissue in the body (Straussman et al., 2009). These
pluripotency genes are re-methylated upon the initial stages of
cell differentiation (Epsztejn-Litman et al., 2008), at which point
cell-speciﬁc DNA methylation patterns begin to develop (Strauss-
man et al., 2009), enabling cells to have speciﬁc structures and
functions.
After embryonic re-establishment, DNA methylation patterns
are maintained by DNMT1 during successive cell divisions (i.e.,
DNA methylation marks are copied from original to nascent
strands during DNA replication) and, as such, are relatively
stable throughout life (particularly during young and middle-
aged adulthood). This maintenance of DNA methylation is not
perfect, however. It has been observed that older monozygotic
twin pairs demonstrate greater DNA methylation differences than
youngermonozygotic twin pairs (Fraga et al., 2005). This so-called
epigenetic drift might be due to the accumulation of small errors in
FIGURE 1 | DNA methylation during development and aging.The
changes in the human methylome can be divided into three stages:
(1) transition from zygote to pre-implantation blastocyst, (2) transition from
implanted blastocyst to early fetal development, and (3) transition into adult
life. Genes and the environment (4) inﬂuence DNA methylation patterns at
each of these stages.
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copying DNA methylation marks during successive cell divisions
(Martin, 2005). The differences between twins were greater for
pairs that spent less of their lifetime together or exhibited more
different lifestyles, suggesting that environmental factors play a
role in epigenetic drift (Fraga et al., 2005). In addition, senescence
is associated with global demethylation of the genome (Bjornsson
et al., 2008; Bollati et al., 2009), possibly due to decreasingDNMT1
activity (Lopatina et al., 2002).
TISSUE-SPECIFICITY OF DNA METHYLATION PATTERNS
A considerable similarity in DNA methylation levels exists across
different tissues. By bisulﬁte-DNA sequencing of human chro-
mosomes in 12 different tissues, it was estimated that only about
5–15% of CpGs are methylated in a tissue-speciﬁc manner (Eck-
hardt et al., 2006). Furthermore, these differential CpGs are more
likely to be found between developmentally distant tissues, such
as liver (derived from endoderm) and kidney (derived from meso-
derm; Pai et al., 2011) than between developmentally close tissues,
such as various types of lymphocytes (all derived from mesoderm;
Eckhardt et al., 2006).
SEX DIFFERENCES IN DNA METHYLATION
A high degree of similarity in DNA methylation patterns also
exists between males and females (Eckhardt et al., 2006; Talens
et al., 2010). Nonetheless, some sex differences do exist. The
most notable is the hypermethylation of gene promoters on X
chromosome that occurs only in females (Hellman and Chess,
2007). This process is initiated during the blastocyst stage (coin-
ciding with global re-methylation of autosomes); it is mediated
by DNMT1 and DNMT3B (Hansen et al., 2000; Csankovszki et al.,
2001), and executed at random with respect to the parental ori-
gin of the inactivated X chromosome (Escamilla-Del-Arenal et al.,
2011). Another sex difference pertains to the frequency of DNA
methylation aberrations, which are more frequent in male than
female aborted or stillborn fetuses (Pliushch et al., 2010). DNA
methylation aberrations are also more easily induced in males
than females by early environments, such as prenatal exposure to
cigarette smoke or a lack of folate (Hoyo et al., 2011; Murphy et al.,
2012a).
Taken together, DNA methylation at any given CpG is the result
of multiple processes that are orchestrated as a developmental cas-
cade involving, ﬁrst, global demethylation after fertilization, then,
cell/tissue-speciﬁc re-methylation during very early embryogene-
sis and, ﬁnally, maintenance of DNA methylation throughout the
remainder of life. Each of these processes depends on the supply
of methyl groups and the catalytic activity of DNA methylation
enzymes (and associated machinery), both of which are regulated
by genetic and environmental factors.
GENETIC AND ENVIRONMENTAL INFLUENCES ON DNA
METHYLATION
Methylation of DNA at a givenCpG is a quantitative trait regulated
by a complex interplay of genetic and environmental factors. Twin
and family-based studies suggest that a signiﬁcant proportion of
inter-individual variability in DNA methylation is determined
genetically (Bjornsson et al., 2008; Kaminsky et al., 2009). DNA
methylation is more similar in monozygotic than dizygotic twins
(Kaminsky et al., 2009) and age-related changes in DNA methy-
lation during adulthood show familial clustering with estimated
heritability of >70% (Bjornsson et al., 2008).
GENETIC INFLUENCES ON DNA METHYLATION
The contribution of genetic factors to DNA methylation may vary
across individual CpGs. Some CpGs are located directly on sin-
gle nucleotide polymorphisms (SNPs) and, if their Cs or Gs are
mutated into other nucleotides, they are not methylated. In these
CpGs, DNA methylation behaves as a monogenic trait, being
“high” in non-mutant homozygotes, “intermediate” in heterozy-
gotes and“low” in mutant homozygotes. Interestingly, such effects
of sequence variation can spread across neighboring CpGs and
thus contribute to the observed correlated nature of DNA methy-
lation at neighboring CpGs (Bell et al., 2011). For example, at a
CpG located on rs10846023 (a T/C SNP), the level of DNA methy-
lation is highly allele-speciﬁc; methylation beta on the T allele
was close to 0%, whereas methylation beta on the C allele was
>60% (Shoemaker et al., 2010). This effect of allele speciﬁcity was
exhibited at nearby CpGs, spanning over 500 bp (Shoemaker et al.,
2010).
Further support forDNAmethylation being in part determined
genetically comes from genome-wide association studies (GWAS)
testing genotype–phenotype associations between>600,000 SNPs
and DNA methylation at>25,000 CpGs (Bell et al., 2011; Numata
et al., 2012). These GWAS identiﬁed a large number of SNPs
(∼3,000) associated with the level of DNA methylation at var-
ious CpGs; most of them were located within 2-kb regions of
interrogated CpGs, but some were further apart or even on differ-
ent chromosomes (Bell et al., 2011; Numata et al., 2012). Of note,
given the large number of statistical tests typically performed in a
GWAS of DNA methylation (i.e., 600,000 SNPs × 25,000 CpGs)
and the need for correction for multiple comparisons, only SNPs
with very large effects (explaining >20% of variance at a given
CpG) have been reported, thus leaving out undiscovered SNPs
with smaller but likely biologically meaningful effects.
Other than creating or abolishing a CpG by mutation, the
mechanisms of how DNA variants modulate DNA methylation
are not well understood. The results of the above GWAS suggest
that some mechanisms may be regional, whereas others may be
more global, or even genome-wide. The SNPs associated with
DNA methylation at nearby CpGs are likely to exert regional
effects; these may be related to speciﬁc sequence variants inter-
fering with the action of the DNA methylation machinery (Handa
and Jeltsch, 2005). For example, in vitro studies suggest that the
de novo methyltransferases DNMT3A and DNMT3B may have
intrinsic preferences for certain ﬂanking sequences (Jurkowska
et al., 2011) and that the DNMT3A/DNMT3L complex favors
methylation of CpGs distributed periodically and separated by dis-
tances of 8–10 bp (Jia et al., 2007). The SNPs associated with DNA
methylation at multiple distant CpGs located across large regions
and on different chromosomes are likely exerting more global
effects; these may be related to sequence variants modulating the
expression or catalytic activity of enzymes involved in the process
of DNA methylation. For example, a recent GWAS identiﬁed a
SNP associated with global level of DNA methylation, which was
located in the gene encoding disco-interacting protein 2 homolog
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B (DIP2B; Bell et al., 2011); this protein contains a DNA methyl-
transferase 1-associated protein 1-binding domain and, as such,
may be part of theDNAmethylationmachinery (Winnepenninckx
et al., 2007). In the same study, a weaker association with global
DNA methylation levels was found near DNMT1, which encodes
the key enzyme for DNA methylation maintenance (described in
Section “DNA Methylation”; Bell et al., 2011). Apart from GWAS,
candidate-gene studies revealed additional genes associated with
global DNA methylation level; these were the methylenetetrahy-
drofolate reductase gene (MTHFR; Castro et al., 2004), which
encodes an enzyme involved in the generation of methyl groups
required for DNA methylation (Foley et al., 2009), and DNMT3B
(Murphy et al., 2012b), which is one of the two key de novo DNA
methyltransferases (described in Section “DNA Methylation”).
ENVIRONMENTAL INFLUENCES ON DNA METHYLATION
Methylation of DNA may also be modiﬁed by environmental
factors (Terry et al., 2011). Environments acting during early
embryogenesis (e.g., when global erasure and re-establishment
of DNA methylation occur) may induce extensive, soma-wide
modiﬁcations of DNA methylation, whereas environments acting
later during life are more likely to induce less extensive, tissue-
speciﬁc modiﬁcations of DNA methylation (Figure 1). The former
may be involved in fetal programing of adult disorders (Suter and
Aagaard, 2012), whereas the latter may play a role in tissue-speciﬁc
carcinogenesis (for example, Ehrlich and Lacey, 2013). One envi-
ronment implicated in both these effects is exposure to cigarette
smoke.
EXPOSURE TO CIGARETTE SMOKE
Cigarette smoking is still common, despite well-publicized adverse
consequences on health (reviewed in Sherman, 1991). In Canada
and the USA, for example, ∼20% of all adults and ∼10% of preg-
nant women smoke at present (Centers for Disease Control and
Prevention, 2011; Health Canada, 2011; Haghighi et al., 2013). It
is well established that (1) active cigarette smoking is a major risk
factor of cancer, cardiovascular disease, and chronic obstructive
pulmonary disease (Kannel et al., 1987; Bartecchi et al., 1994; Doll
et al., 1994) and (2) prenatal exposure to cigarette smoke causes
fetal growth restriction prenatally, increases risk for sudden infant
death syndrome postnatally and promotes the development of
addictive behavior, immune-system abnormalities, obesity and
associated cardiometabolic diseases postnatally (Power et al., 2010;
Syme et al., 2010; Winans et al., 2011; Haghighi et al., 2013). Part
of these effects may be mediated through cigarette smoke-induced
modulations of DNA methylation.
Cigarette smoke is considered one of the most powerful envi-
ronmental modiﬁers of DNA methylation (Breitling et al., 2011).
The speciﬁc mechanisms of how cigarette smoke may alter DNA
methylation are becoming better understood (Figure 2). First,
cigarette smoke may modulate it through DNA damage and sub-
sequent recruitment of DNMTs. Carcinogens in cigarette smoke,
such as arsenic, chromium, formaldehyde, polycyclic aromatic
hydrocarbons, and nitrosamines (Smith and Hansch, 2000; Suter
et al., 2010), can damage DNA by causing double-stranded breaks,
as shown in mouse embryonic stem cells exposed to cigarette-
smoke condensate (Huang et al., 2012). In these experiments,
survivor cells display a high capacity for DNA repair and nor-
mal karyotypes (Huang et al., 2012). The DNA repair sites recruit
DNMT1 (Mortusewicz et al., 2005), which methylates CpGs adja-
cent to the repaired nucleotides (Cuozzo et al., 2007). Second,
cigarette smoke may also modulate DNA methylation through
nicotine effects on gene expression (Lee and D’Alonzo, 1993).
Nicotine binds to and activates the nicotinic acetylcholine recep-
tors (present abundantly in the central and peripheral nervous
systems) and thus increases intracellular calcium and leads to
downstream activation of cAMP response element-binding pro-
tein, a key transcription factor for many genes (Shen and Yakel,
2009). Acting possibly through this pathway, nicotine has been
shown to downregulate DNMT1 mRNA and protein expression
in mouse brain neurons (Satta et al., 2008). Third, cigarette smoke
may alter DNA methylation indirectly through the modulation of
expression and activity of DNA-binding factors. It has beendemon-
strated, for example, that cigarette-smoke condensate increases
Sp1 expression and binding to DNA in lung epithelial cells (Mer-
cer et al., 2009; Di et al., 2012). Sp1 is a common transcription
factor that binds to GC-rich motifs in gene promoters (Kadon-
aga et al., 1987) and plays a key role in early development; as
such, it may prevent de novo methylation of CpGs within these
motifs during early embryogenesis (Han et al., 2001). Fourth,
cigarette smoke may alter DNA methylation via hypoxia – cigarette
smoke contains carbonmonoxide that binds to hemoglobin (com-
petitively with oxygen) and thus decreases tissue oxygenation
(Olson, 1984). Hypoxia, in turn, leads to the HIF-1α-dependent
upregulation of methionine adenosyltransferase 2A, which is an
enzyme that synthesizes S-adenosylmethionine, a major bio-
logical methyl donor critical for DNA methylation processes
(Liu et al., 2011).
Below we review studies investigating the alterations of DNA
methylation associated with current and prenatal exposures
to cigarette smoke. We focus mainly on studies employing
epigenome-wide technologies (see Box 1).
CURRENT EXPOSURE TO CIGARETTE SMOKE AND DNA METHYLATION
Several epigenome-wide studies have examined whether cigarette
smoking is associated with modiﬁcations of DNA methylation.
One of the ﬁrst ones was conducted with the Illumina 27K Methy-
lation BeadChip, which interrogates DNA methylation at>27,000
CpG sites located mostly in gene promoters (Breitling et al., 2011).
This study, conducted with DNA from peripheral lymphocytes,
identiﬁed a differentially (smokers vs. non-smokers) methylated
CpG site in the protease-activated receptor 4 gene (F2RL3), achiev-
ing Bonferroni-corrected signiﬁcance threshold (p< 1.81× 10−6)
formultiple testing of>27,000CpGs (Breitling et al., 2011). At this
site, DNA methylation was signiﬁcantly lower in smokers than
non-smokers (% methylation difference = 12%; p = 2.7 × 10−31)
and correlated negatively with the number of smoked cigarettes
and positively with the duration of smoking abstinence (Bre-
itling et al., 2011). Similar exposure-related differences in the
methylation of this gene were also seen in another indepen-
dent study (% methylation difference = 8%; p = 8.4 × 10−11;
Shenker et al., 2012). Interestingly, F2RL3 is involved in platelet
activation and intimal hyperplasia and inﬂammation – DNA
methylation changes in this gene may represent a mechanistic link
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FIGURE 2 | Effects of cigarette smoke exposure on DNA methylation.
Cigarette smoke has been shown to modulate DNA methyltransferase 1
(DNMT1) content, both at the transcript and protein level, and enzymatic
activity separately in different cell types. Double-stranded DNA breaks
may be induced by cigarette smoke, which subsequently recruits DNMT1
adjacent to the repair site. DNA-binding proteins, such as Sp1, are
activated by cigarette smoke and protect CpG sites from de novo
methylation. In the context of prenatal exposure, cigarette smoke
induces hypoxia in the embryo, which in turn modulates methyl group
availability.
between cigarette smoking and cardiovascular disease (Breitling
et al., 2011).
More recent studies have been conducted with the Illumina
450K Methylation BeadChip, which interrogates >450,000 CpG
sites located not only in gene promoters but also in gene bod-
ies and intergenic regions (Sandoval et al., 2011). These studies
replicated the previous F2RL3 ﬁndings and identiﬁed further CpG
sites methylated differentially between smokers and non-smokers.
Among the latter ones, most signiﬁcant were those found in the
body of the aryl hydrocarbon receptor repressor gene (AHRR;
Monick et al., 2012; Shenker et al., 2012). At these sites, DNA
methylation was signiﬁcantly lower in smokers than non-smokers
in two different tissues, at a Bonferroni-corrected signiﬁcance
threshold of p < 10−7, namely the lungs (% methylation dif-
ference = 34%; p = 1.97 × 10−9) and peripheral lymphocytes
(% methylation difference = 17%; p = 2.3 × 10−15; Monick
et al., 2012; Shenker et al., 2012). When tested in the lungs, DNA
methylation correlated inversely with the levels of AHRR mRNA
in both smokers and non-smokers (Monick et al., 2012). AHRR
encodes a transcription factor that inhibits the aryl hydrocarbon
receptor pathway, which enhances the expression of detoxiﬁcation
(xenobiotic-metabolizing) enzymes of environmental pollutants,
such as polycyclic aromatic hydrocarbons contained in cigarette
smoke (Opitz et al., 2011). Thus, cigarette smoking-induced
decreases in AHRR DNA methylation and related increases in
AHRR expression may compromise the body’s capacity to metab-
olize and thus remove harmful environmental chemicals, and as
such may represent a potential mechanism of increased risk of
carcinogenesis in smokers.
Finally, it shouldbenoted that cigarette smokingmay alterDNA
methylation inmultiple tissues (Hammons et al., 1999; Peters et al.,
2007; Suzuki et al., 2007; Satta et al., 2008), and some of these
alterations may differ between the tissues. Most of the current
investigations, however, utilized DNA from peripheral lympho-
cytes or buccal cells only (due to the ease of their sampling)
and, thus, did not examine this potential tissue variability. Fur-
thermore, several epigenome-wide studies of disease outcomes
closely related to cigarette smoking have been conducted (e.g.,
lung cancer; Carvalho et al., 2012 and chronic obstructive pul-
monary disease; Qiu et al., 2012), but they did not examine effects
of cigarette smoking per se. As such, these studies are outside
the scope of the present review. Epigenetic signatures of disease
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BOX 1 | Methods of measuring DNA methylation.
Locus-specific DNA methylation
• Bisulﬁte pyrosequencing (Frommer et al., 1992): Detects DNA
methylation at single-CpG resolution over a short span of DNA
(<1 kb) and requires only a small amount of DNA for analysis.
It is a quantitative sequencing method used for a pre-selected
genomic region.
Locus-independent global DNA methylation
• Bisulﬁte pyrosequencing of repetitive DNA elements (Breton
et al., 2009): Methylation of repetitive DNA sequences, such
as long interspersed elements (LINEs), short interspersed ele-
ments (SINEs), and satellite DNA, have been used as markers of
global DNA methylation, as these elements are abundantly found
throughout the genome.
• ELISA-based methylation assay (Guerrero-Preston et al., 2010):
Uses methylcytosine-speciﬁc antibodies to quantify the relative
DNA methylation between samples.
• [3H]-methyl acceptance assay (Terry et al., 2008): Relies on SssI
prokaryotic methylase to incorporate [3H]-labeled methyl groups
at all unmethylatedCpGs. Amount of incorporated [3H] is inversely
proportional to endogenous DNA methylation.
• Luminometric methylation assay (LUMA; Karimi et al., 2006):
Relies on genomic cleavage by methylation-sensitive and -
insensitive restriction enzymes; difference in amount of cleavage
between these two types of enzymes is a readout for global
methylation.
Epigenome-wide DNA methylation
• Reduced representation bisulﬁte sequencing (RRBS; Gu et al.,
2011): Uses next-generation sequencing technology on bisulﬁte-
converted DNA fragments, enriched at CpG-dense regions of the
genome to reduce amount of sequencing required.
• Illumina 450K Methylation BeadChip (Dedeurwaerder et al.,
2011): A robust high-throughputmethylationmicroarray, providing
coverage to over 480,000 CpG sites across 96% of CpG islands
and 99% of RefSeq genes across the genome.
• Illumina GoldenGate Assay for Methylation (McRonald et al.,
2009): This platform utilizes pre-selected CpG sites within genes
relevant for speciﬁc diseases or pathways, such as the Golden-
Gate Methylation Cancer Panel I, which spans 1,505 CpG loci
from 807 cancer-related genes.
outcomes closely related to cigarette smoking have been reviewed
recently in Sundar et al. (2011).
PRENATAL CHRONIC EXPOSURE TO CIGARETTE SMOKE AND DNA
METHYLATION
Cigarette smokemay inﬂuence the fetus in a number of ways, some
of which may also alter DNA methylation. The latter include cer-
tain chemicals in cigarette smoke (e.g., carcinogenic xenobiotics
and nicotine) that can pass through the placenta to the developing
embryo and fetus (Lambers and Clark, 1996). The passage of some
of these chemicals is diminished by the detoxifying capacity of pla-
centa (i.e., it metabolizes harmful xenobiotics; Sanyal et al., 1994;
Suter and Aagaard, 2012). One molecule involved in this function
is cytochrome P450 (CYP1A1), which is a phase-I enzyme in a
two-phase detoxifying pathway (Nebert and Dalton, 2006). Pre-
natal exposure to cigarette smoke has been associated with lower
DNAmethylationofCYP1A1 atCpGsites surrounding the xenobi-
otic response-element, which is a major transcriptional enhancer
of CYP1A1 expression (Suter et al., 2010). It was also associated
with higher CYP1A1 mRNA expression (Suter et al., 2010). Gene-
speciﬁc effects of prenatal exposure to cigarette smoke on placental
DNAmethylation andmRNAhave also been seen in another study
employing, side-by-side, the Illumina 27K Methylation BeadChip
and the IlluminaHG-12 gene-expression array (Suter et al., 2011).
The authors searched for genes in which promoter DNA methy-
lation is correlated with mRNA expression. They identiﬁed a
signiﬁcantly larger number of such genes in exposed (n = 438)
than non-exposed placentas (n = 25; Suter et al., 2011). Interest-
ingly, many of these genes encoded molecules involved in hypoxia
response- and oxidative stress-regulating pathways (e.g., HIF-1α
signaling; Suter et al., 2011).Whether theseDNAmethylation (and
mRNA) modiﬁcations develop as functional adaptations to the
greater need to detoxify xenobiotics and/or respond to hypoxia in
the exposed placentas remains to be determined.
Prenatal exposure to cigarette smoke has been associated with
alteredDNAmethylationnot only inplacentas but also inoffspring
tissues. Studies examining DNA methylation globally showed that
exposed vs. non-exposed individuals exhibit lower level of DNA
methylation at birth (cord serum,ELISA-basedmethod; Guerrero-
Preston et al., 2010) as well as during childhood (buccal cells,
bisulﬁte conversion, and pyrosequencing of DNA repetitive ele-
ments; Breton et al., 2009) andmiddle-aged adulthood (peripheral
blood cells, [3H]-methyl acceptance assay; Terry et al., 2008). The
most recent study of individual CpGs conductedwith the Illumina
450K Methylation BeadChip suggests that exposure is associated
not only with global changes but also with changes at speciﬁc CpG
sites (Joubert et al., 2012). Examining DNA methylation in cells
from cord blood and assessing prenatal cigarette-smoke expo-
sure by circulating maternal cotinine (a metabolite of nicotine
and a stable biomarker of cigarette smoking), the authors identi-
ﬁed 26 epigenome-wide signiﬁcant CpGs that were differentially
methylated between exposed and non-exposed individuals (Jou-
bert et al., 2012). Among these, the most signiﬁcant were those
located in the xenobiotic-detoxifying genes, namely AHRR and
CYP1A1; as discussed above, these two genes have been shownpre-
viously to be differentially methylated by cigarette smoke. Similar
to the current chronic exposure to cigarette smoke in adult smok-
ers, theCpGs inAHRR showed lowerDNAmethylation in exposed
vs. non-exposed, but in contrast to prenatal chronic exposure to
cigarette smoke in placentas, the CpGs in CYP1A1 demonstrated
higher DNA methylation in exposed vs. non-exposed (Joubert
et al., 2012). The differentially methylated CpGs in CYP1A1 in
cord blood were the same as those in placenta (Suter et al., 2010).
The reasons for these seemingly opposite effects of prenatal expo-
sure to cigarette smoke on DNA methylation in placental and fetal
tissues are not clear at present. It is of note, however, that placental
(vs. fetal) tissues are globally hypomethylated, suggesting potential
differences in the regulation of DNA methylation between the two
types of tissues (Santos et al., 2002; Fuke et al., 2004; Novakovic
et al., 2010; Macaulay et al., 2011).
SUMMARY AND FUTURE DIRECTIONS
Cigarette smoking continues to be a major health problem, and
understanding themechanisms of its effects is an important area of
research. DNA methylation represents an epigenetic modiﬁcation
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that can mediate the effects of cigarette smoke on gene expression,
and ultimately disease-relevant phenotypes. Prenatal chronic expo-
sure to cigarette smoke is an adverse environmental stimulus at a
timewhere theDNAmethylome of the offspring is highly dynamic
and the genome-wide methylation patterns develop; as such, these
changes are likely soma-wide andmaintained throughout life.Cur-
rent cigarette smoking occurs at a time when DNA methylation
patterns are already established, but need to be properly main-
tained during cell divisions. Since cigarette smoke is known to
modulate expression and activity of themaintenancemethyltrans-
ferase DNMT1, actively dividing cells may be more susceptible to
exposure-mediated defects in DNA methylation; this may in part
explain the link between smoking and cancer.
Recent technological developments allow for the interrogation
of CpG methylation status across the genome, and this has uncov-
ered associated CpG sites within candidate genes including those
that have not been previously implicated in cigarette smoking
(Joubert et al., 2012). Remarkably, in both prenatal and current
cigarette smoke exposure, similar genes, such as those involved
in chemical detoxiﬁcation (AHRR, CYP1A1), are differentially
methylated, suggesting that smoking effects might be targeted
to speciﬁc regions of the epigenome. Cigarette smoking may
also have shared global consequences, as both prenatal and cur-
rent exposures are associated with epigenome hypomethylation
(Guerrero-Preston et al., 2010; Shigaki et al., 2012). In medicine,
there is a growing practice of using the individualized genome to
understand a patient’s health and disease, but interpreting such
information is dependent on epigenetics, such as DNA methyla-
tion. “Epigenotyping” patients to complement genomic data may
be necessary in the near future.
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